LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Following Suit: Medical Malpractice and Medical “Never Events”
Jan-29-14 • In December 2012, Johns Hopkins released the shocking results of a cautious and rigorous analysis of national medical malpractice claims , believed to be the first of its kind. Among the findings, Johns Hopkins patient safety researchers estimated a surgeon in the United States leaves a foreign object such as a sponge or a towel inside a patient&r... - Januvia Pancreatitis Victim Blames Doctor and Merck
Jan-28-14 Fort Myers, FL Matthew had only taken Januvia for two weeks but he wound up in hospital with acute pancreatitis anyway. He blames the diabetes drug because he was diagnosed with pancreatitis back in 2002, and should never have been prescribed Januvia. Last December, Matthew was diagnosed with type 2 diabetes and his doctor prescribed Metformin, whi... - Adderall’s “Stupid” Factor
Jan-23-14 Washington, DC: It’s no surprise that Adderall is constantly in the news, given the preposterous increase in diagnosed ADHD disorders. With that comes an increase in Adderall prescriptions, many of which wind up on the street. Dr. Conners, a psychologist and professor emeritus at Duke University, told the New York Times (December 14, 2013) t... - FDA Issues Warning of Liver Injury with Acetaminophen
Jan-15-14 Washington, DC The FDA has issued a statement recommending health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per tablet, capsule or other dosage unit. The FDA appears to be doing this based on the fact that “there are no available... - Plaintiff to State Supreme Court Over Home Cladding Issue
Jan-9-14 Raleigh, NC A Home Warranty Lawsuit about to be heard by the North Carolina Supreme Court later this month could reverberate throughout the home building industry. At issue, at least in North Carolina, is the state’s statute of repose, which holds that a homeowner cannot go after a builder or a provider of a warranted product beyond six years fro... - New Study Suggests Link Between Victoza and Pancreatitis
Dec-26-13 Ferrara, Italy A new study by researchers in Italy suggests a link between Victoza and pancreatitis. The study, which appears to confirm previous findings about Victoza side effects, examined adverse drug reactions linked to drugs in the incretin mimetic group, a class of drugs that includes Victoza. The study was published in the journal Expert Op... - Despite Safyral and Drospirenone Concerns, It’s Business As Usual at Bayer
Dec-24-13 Leverkusen, Germany It’s interesting to note that Bayer’s Third Quarter (Q3) report was released October 31, a date most equate with the observance of Halloween and all things scary. Dressing up is also a hallmark of the Halloween fun, and to that end, there is no shortage of dressing up in any typical corporate report that strives to dispense... - BBB Reports Debt Collector Harassment Complaints Up 58 Percent
Dec-7-13 Washington, DC The Better Business Bureau (BBB) is that venerable consumer group known for rating companies, businesses and corporations doing commerce in America, and in so doing providing a snapshot to the consumer of the company they’re dealing with. Lately, the BBB has begun to comment on the thorny issue of bill collector harassment . The... - J&J Reaches $2.5B ASR XL Hip Replacement Settlement
Nov-20-13 Washington, DC Further to announcements made last week, Johnson & Johnson (J&J) has said it will pay $2.5 billion to settle nearly 8,000 DePuy hip replacement lawsuits. DePuy Orthopaedics, a unit of J&J, withdrew its ASR XL Acetabular metal-on-metal hip replacement on August 24, 2010 following nearly 300 complaints from people underg... - Add Atrial Fibrillation to List of Fosamax Side Effects
Nov-10-13 New York, NY For the past few years, Fosamax has been associated with femur fractures and jaw necrosis, or death of the jaw bone. Add atrial fibrillation, also known as “Afib,” to the list of Fosamax side effects, and Fosamax risks would more than outweigh the benefits. A new study published in Chest (October 2013), the official pu... - Zimmer NexGen “No Cane No Pain”—No Way
Nov-1-13 Seattle, WA Jim regrets believing Zimmer’s promise of “No Cane No Pain” after Zimmer NexGen knee replacement surgery. And since surgery, his travel plans have gone sideways. “I did a lot of research with my doctor; we looked at different knee brands available and the Zimmer came out on top due to its flexibility,” says Ji... - Do the Monster Math: Monster Energy Drinks
Oct-31-13 Washington, DC About a year ago Monster Energy was hit with a wrongful death lawsuit by the parents of 14-year-old Anais Fournier. Since that time, LawyersandSettlements has received a number of complaints regarding Monster Energy Drink Injury, mainly from parents of young men who have suffered high blood pressure, heart attack and even death. The Fo... - LawyersandSettlements.com Interviews Debt Collector Harassment Attorney Regarding Abusive Collection Tactics
Oct-30-13 Consumers continue to endure debt collector harassment, in spite of regulations designed to prevent such tactics under the federal Fair Debt Collection Practices Act. LawyersandSettlements.com spoke with attorney Ben Stewart regarding unfair and abusive collection practices, and what consumers can do to avoid becoming victims of bill collector harassment... - GSK to Face Avandia Racketeering Class Action Lawsuits
Oct-29-13 New York, NY GlaxoSmithKline (GSK) LLC is facing three federal racketeering class actions, alleging the pharmaceutical company concealed the risk of adverse cardiovascular effect associated with its diabetes drug Avandia, and that it duped health benefit payors into covering the expensive prescriptions. In her ruling, US District Judge Cynthia M. Ruf... - Topamax Lawsuit Underway
Oct-26-13 Philadelphia, PA A Topamax lawsuit alleging that Topamax side effects include a risk of birth defects is underway in Philadelphia. The lawsuit alleges Janssen Pharmaceuticals did not warn expectant mothers about the risk of Topamax side effects in children. As reported by Businessweek (10/15/13), the lawsuit was filed by April Czimmer, who used To... - Did Intuitive Downplay Risks Associated with daVinci Robot?
Oct-12-13 Irvine, CA A report in the Orange County Register (9/20/13) suggests that two surgeons have been working with Intuitive Surgical Inc to downplay the alleged risks associated with the daVinci surgical robot . Intuitive Surgical has come under fire recently for problems with the daVinci robot allegedly resulting in operating room injuries to patients. T... - Lawsuit Updates: The Latest on Lipitor & Crestor
Oct-9-13 A mounting number of Lipitor diabetes lawsuits have been filed against Pfizer, the maker of the medication. Lipitor, also known generically as atorvastatin, is a member of the statin class of medications used to reduce blood levels of low-density lipoprotein (LDL) cholesterol, or “bad” cholesterol, a contributing factor in heart disease... - Yasmin Death Toll and Settlements
Sep-30-13 San Francisco, CA Bayer recently announced it had settled close to 7,000 Yasmin and/or Yaz lawsuits for about $1.4 billion, a seemingly staggering sum of money, except when you consider the death toll. In July, documents obtained from Health Canada found that 23 women in Canada had died mainly from blood clots associated with Yasmin or Yaz. These... - Swindled Seniors: Former California Judge to Be Sentenced, Florida Lawsuit Continues
Sep-23-13 Fort Myers, FL An elderly woman who earned just $1,800 in monthly income between her Social Security check and her pension was somehow persuaded to take out a life insurance policy worth $7.5 million. According to her son’s financial elder abuse attorney, the woman was saddled with a trust and allegedly persuaded to take out a loan valued at $1.1 mil... - Regulators Have Called Off the Dogs, but Concern Over Januvia Lingers
Sep-5-13 Washington, DC The US Food and Drug Administration (FDA) appeared quick to follow the lead of the European Medicines Agency (EMA) when it concluded there was insufficient data to warrant label changes to Merck’s Januvia and other GLP-1 drugs over concerns for pancreatitis and pancreatic cancer, including Januvia pancreatic cancer . The American Di...